Gumen, Joan A.
HRN: 17-17-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
CEFUROXIME 500MG (TAB)
05/26/2022
06/01/2022
PO
500mg
BID X 7 Days
Pus Cells: 4-10; WBC: 13.1
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes